Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.

Kathryn Coyle,Doug Coyle,Isabelle Nault,Ratika Parkash,Jeffrey S Healey,Christopher J Gray,Martin J Gardner,Laurence D Sterns,Vidal Essebag,Tomasz Hruczkowski,Louis Blier,George A Wells,Anthony S L Tang,William G Stevenson,John L Sapp

JACC: Clinical Electrophysiology（2018）

引用 28|浏览0

暂无评分

摘要

For the total trial population, results are suggestive that ablation is cost effective compared with escalation of drug therapy. This result was only manifest for the subgroup of patients whose qualifying arrhythmia occurred despite amiodarone.

查看译文

关键词

antiarrhythmic drug therapy,catheter ablation,cost effectiveness,implantable cardioverter-defibrillator,ventricular tachycardia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要